PODD Insulet Corporation
Company Analysis
Latest News
🔴 Insulet is trading 23% down today as 2026 sales guidance cut offsets Q2 beat
Insulet is trading 23% down at $131.65 after its second-quarter earnings release showed strong revenue and EPS beats but a cut to full-year 2026 sales...
🔴 Insulet is trading 10.1% down today on lowered FY26 sales outlook and Omnipod guidance
Insulet is trading 10.1% down at $149.98 after the company lowered its long-term sales outlook despite beating Q2 earnings expectations. • The company cut its...
Insulet's second quarter revenue grew 23.5% to beat estimates, but the company lowered its full-year 2026 sales forecast.
Insulet reported second quarter revenue of $801.7 million, up 23.5% year-over-year, and adjusted EPS of $1.66. These results surpassed analyst expectations for...
Insulet Corporation Q2 2026 Earnings Preview: What Analysts Expect on August 05, 2026
Analysts expect Insulet to report Q2 2026 revenue of $787.4 million and earnings of $1.44 per share, with the stock currently trading at $165.35 against an...
🔴 Insulet is trading 4.6% down today as managed care concerns weigh on healthcare
Insulet is trading at $161.99 (4.6% down) as managed care concerns drag the broader healthcare sector lower despite positive performance in the wider...
Insulet Tumbles as UBS Slashes Omnipod Maker’s Price Target to $174
UBS downgraded Insulet Corp. (PODD) from Buy to Neutral on July 28, 2026. The investment bank slashed its price target for the medical device company to...
🟢 Insulet is trading 4.4% up today amid a broader healthcare sector bid
Insulet is trading at $172.25 (+4.40%) amid a broader healthcare sector bid and a rotation into defensive names, despite a lack of company-specific news. •...
🟢 Insulet is trading 4.2% up today despite broader healthcare sector weakness
Insulet is trading 4.2% higher at $166.13, moving notably above its recent $150–$160 range despite a lack of fresh company-specific catalysts. • No new...
🔴 Insulet shares fall 4.5% as class-action lawsuit filed today
• Insulet (PODD) is trading at $156.47 (-4.53%) today after a class-action lawsuit was filed against the company for securities fraud. • The lawsuit, announced...
Insulet's 6% Bounce Defies a Bruising Selloff — But Can Strong Sales Outrun a Growing Legal Cloud?
Shares of Insulet Corporation surged 6.1% to $174.55 on July 6, as bargain hunters stepped in following months of punishing declines. The stock has cratered...
🟢 PODD is trading 6.1% up today as investors reassess legal risks and fundamental strength
PODD is trading 6.1% up at $174.55 as investors reassess recent legal risks against the company's fundamental strength and upcoming earnings. • The move...
Insulet Hit With Class Action, Alleging Omnipod Insulin Under-Delivery
Pomerantz LLP filed a class action lawsuit against Insulet Corporation on July 3, 2026. The complaint alleges that Insulet and its officers violated federal...
🟢 PODD is trading 4.8% up today as it extends a sharp intraday rebound
PODD is trading at $167.53 (+4.84%) in after-hours trading, extending gains from a strong regular-session rebound on July 1. • The move appears to be driven...
🟢 PODD extends move to 5.2% up
PODD is trading at $160.21, up 5.2% versus the comparison close of $152.25 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 PODD is trading 4.2% up today as analyst price targets signal 57% upside potential
PODD is trading 4.2% up at $158.65 as investors focus on the long-term growth narrative following a reset in analyst price targets. • New coverage from 23...
Insulet Surges 16% in Three Days on Deutsche Bank's Bullish Call — But Can a Beaten-Down Diabetes Stock Really Close a $29 Gap to Its Target?
Shares of Insulet Corporation vaulted to $161.41 in after-hours trading Wednesday, capping a 16% three-day rally from last Monday's close of $138.97 — a level...
🟢 PODD is trading 8.4% up today, extending a rebound fueled by a bullish Deutsche Bank initiation
PODD is trading at $161.41 (8.4% up) in after-hours trading, extending a sharp rebound from last week’s selloff. • The move follows bullish sentiment sparked...
🟢 PODD Surges 4.8% as Deutsche Bank Initiates 'Buy' Rating
Insulet Corporation (PODD) shares are trading at $145.57 (+4.8%) after Deutsche Bank initiated coverage with a Buy rating and a $190.00 price target today. •...
🔴 Insulet Corporation is trading 4.5% down today with no clear catalyst
Insulet Corporation is trading 4.5% down at $139.27 today amid a lack of fresh headlines, suggesting the move is driven by normal volatility and positioning...
🟢 Insulet Corporation is trading 4.5% up today as it bounces from a sharp regular-session drop
Insulet Corporation is trading at $157.49 (+4.50%) in after-hours trading, rebounding from a sharp decline during the regular session on June 10. • No...